BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 34352356)

  • 1. Imaging-based programming of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Waldthaler J; Bopp M; Kühn N; Bacara B; Keuler M; Gjorgjevski M; Carl B; Timmermann L; Nimsky C; Pedrosa DJ
    Brain Stimul; 2021; 14(5):1109-1117. PubMed ID: 34352356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease.
    Lönnfors-Weitzel T; Weitzel T; Slotboom J; Kiefer C; Pollo C; Schüpbach M; Oertel M; Kaelin A; Wiest R
    Neuroimage Clin; 2016; 12():832-837. PubMed ID: 27843765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Subthalamic Nucleus Deep Brain Stimulation and Retention Delay on Memory-Guided Reaching Performance in People with Parkinson's Disease.
    Trevarrow MP; Munoz MJ; Rivera YM; Arora R; Drane QH; Rosenow JM; Sani SB; Pal GD; Verhagen Metman L; Goelz LC; Corcos DM; David FJ
    J Parkinsons Dis; 2023; 13(6):917-935. PubMed ID: 37522216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7-Tesla Magnetic Resonance Imaging Scanning in Deep Brain Stimulation for Parkinson's Disease: Improving Visualization of the Dorsolateral Subthalamic Nucleus.
    Verlaat L; Rijks N; Dilai J; Admiraal M; Beudel M; de Bie RMA; van der Zwaag W; Schuurman R; van den Munckhof P; Bot M
    Mov Disord Clin Pract; 2024 Apr; 11(4):373-380. PubMed ID: 38385792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated deep brain stimulation programming based on electrode location: a randomised, crossover trial using a data-driven algorithm.
    Roediger J; Dembek TA; Achtzehn J; Busch JL; Krämer AP; Faust K; Schneider GH; Krause P; Horn A; Kühn AA
    Lancet Digit Health; 2023 Feb; 5(2):e59-e70. PubMed ID: 36528541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion image-based programming after subthalamic nucleus deep brain stimulation.
    Paek SH; Kim HJ; Yoon JY; Heo JH; Kim C; Kim MR; Lim YH; Kim KR; Kim JW; Han JH; Kim DG; Jeon BS
    World Neurosurg; 2011; 75(3-4):517-24. PubMed ID: 21600506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation on gait kinematics in Parkinson's disease: a randomized, blinded study.
    Lizarraga KJ; Jagid JR; Luca CC
    J Neurol; 2016 Aug; 263(8):1652-6. PubMed ID: 27278062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep brain stimulation outcomes in patients implanted under general anesthesia with frame-based stereotaxy and intraoperative MRI.
    Matias CM; Frizon LA; Nagel SJ; Lobel DA; Machado AG
    J Neurosurg; 2018 Dec; 129(6):1572-1578. PubMed ID: 29372880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic Stimulation for Camptocormia in Parkinson's Disease: Association of Volume of Tissue Activated and Structural Connectivity with Clinical Effectiveness.
    Lai Y; Song Y; Huang P; Wang T; Wang L; Pan Y; Sun Q; Sun B; Zhang C; Li D
    J Parkinsons Dis; 2021; 11(1):199-210. PubMed ID: 33325395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of local field potential-guided programming for deep brain stimulation in Parkinson's disease: A comparison with clinical and neuro-imaging guided approaches in a randomized, controlled pilot trial.
    Binder T; Lange F; Pozzi N; Musacchio T; Daniels C; Odorfer T; Fricke P; Matthies C; Volkmann J; Capetian P
    Brain Stimul; 2023; 16(5):1243-1251. PubMed ID: 37619891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter tracts involved by deep brain stimulation of the subthalamic nucleus in Parkinson's disease: a connectivity study based on preoperative diffusion tensor imaging tractography.
    Vassal F; Dilly D; Boutet C; Bertholon F; Charier D; Pommier B
    Br J Neurosurg; 2020 Apr; 34(2):187-195. PubMed ID: 31833430
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of indirect and direct targeted STN DBS in the treatment of Parkinson's disease-surgical method and clinical outcome over 15-year timespan.
    Lahtinen MJ; Haapaniemi TH; Kauppinen MT; Salokorpi N; Heikkinen ER; Katisko JP
    Acta Neurochir (Wien); 2020 May; 162(5):1067-1076. PubMed ID: 32103343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDS-UPDRS to assess non-motor symptoms after STN DBS for Parkinson's disease.
    Jafari N; Pahwa R; Nazzaro JM; Arnold PM; Lyons KE
    Int J Neurosci; 2016; 126(1):25-9. PubMed ID: 26134878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective network of deep brain stimulation of subthalamic nucleus with bimodal positron emission tomography/functional magnetic resonance imaging in Parkinson's disease.
    Chen HM; Sha ZQ; Ma HZ; He Y; Feng T
    CNS Neurosci Ther; 2018 Feb; 24(2):135-143. PubMed ID: 29222835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.